Brussels’ initiative to loosen regulations on chemicals is jeopardizing the European Union’s reputation as a leader in environmental policy and the rule of law, warns a prominent U.N. human rights official in a recent letter.
“Simplicity and efficiency should not come at the expense of retrogressive measures or the health of the population, especially those that are the most vulnerable to toxics and pollution such as children,” writes U.N. Special Rapporteur on Toxics and Human Rights Marcos Orellana.
Orellana’s concerns stem from a proposal released by the European Commission this past summer, which aims to simplify a series of laws that cover cosmetics, fertilizers, and chemical classifications under a comprehensive “chemicals omnibus” bill. This legislation is part of the EU’s broader effort to streamline regulations, potentially easing the burden on businesses and stimulating economic growth.
Potential risks to public health and safety
Despite its intended benefits, Orellana argues that the proposal appears to clash with rights outlined in the Charter of Fundamental Rights of the European Union, particularly those related to health and environmental protection. In his letter, dated September 25, addressed to the EU’s U.N. delegation, he articulates specific concerns regarding the possible relaxation of rules surrounding hazardous substances.
One contentious aspect of the bill suggests loosening restrictions on carcinogenic chemicals in cosmetics, a move that has provoked strong criticism from consumer advocacy groups who argue it could jeopardize public health.
Orellana expresses particular alarm over the proposed reductions in safeguards against harmful substances classified as carcinogenic, mutagenic, or reproductive toxins in personal care products. He also raises issues concerning new flexibilities in product labeling and advertising, noting that the bill has yet to undergo a comprehensive impact assessment.
Industry response and ongoing negotiations
As it stands, Orellana warns that there is a significant risk the proposal could negatively affect human rights, including the right to health and a clean environment. He points out that it could potentially reverse recent advances in public health protections and create uncertainty for businesses that have already made investments in compliance with current regulations.
Furthermore, he challenges the EU to clarify how the omnibus package will align with international human rights standards, indicating a need for transparency in the legislative process.
In contrast, industry stakeholders such as the European Chemical Industry Council and Cosmetics Europe have expressed support for the bill, with Cosmetics Europe asserting that the proposed changes will not compromise consumer safety. The legislative package is currently under negotiation by the European Parliament and EU member states.